{"transactions":[{"id":684014,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:02:24.000Z","date":"2026-08-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":4714,"price":79.86,"value":376460.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,262 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":122687,"source":{"system":"sec-edgar","filing":"0001470831-26-000835","document":"wk-form4_1787090542.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000835/wk-form4_1787090542.xml","form_type":"4"}},{"id":699096,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-08-03T20:20:53.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":80.06,"value":160120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025."}],"balance_after":127401,"source":{"system":"sec-edgar","filing":"0001470831-26-000745","document":"wk-form4_1785788451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000745/wk-form4_1785788451.xml","form_type":"4"}},{"id":772715,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-05-19T20:26:42.000Z","date":"2026-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":4714,"price":66.13,"value":311736.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,260 shares of Common Stock underlying the Reporting Person's RSUs."}],"balance_after":129401,"source":{"system":"sec-edgar","filing":"0001470831-26-000471","document":"wk-form4_1779222400.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000471/wk-form4_1779222400.xml","form_type":"4"}},{"id":794204,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-05-04T20:22:25.000Z","date":"2026-04-30","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":71.58,"value":143160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025."}],"balance_after":134115,"source":{"system":"sec-edgar","filing":"0001470831-26-000410","document":"wk-form4_1777926142.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000410/wk-form4_1777926142.xml","form_type":"4"}},{"id":832601,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:32:18.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":14170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2026, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":136115,"source":{"system":"sec-edgar","filing":"0001470831-26-000302","document":"wk-form4_1774038735.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000302/wk-form4_1774038735.xml","form_type":"4"}},{"id":877731,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:11:15.000Z","date":"2026-02-26","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":66,"value":132000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025."}],"balance_after":121945,"source":{"system":"sec-edgar","filing":"0001470831-26-000225","document":"wk-form4_1772226672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000225/wk-form4_1772226672.xml","form_type":"4"}},{"id":897525,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-18T23:39:24.000Z","date":"2026-02-17","kind":"sale","planned":true,"acquired":false,"shares":510,"price":74.31,"value":37898.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025."}],"balance_after":123945,"source":{"system":"sec-edgar","filing":"0001470831-26-000186","document":"wk-form4_1771457961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000186/wk-form4_1771457961.xml","form_type":"4"}},{"id":897524,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-18T23:39:24.000Z","date":"2026-02-16","kind":"tax_withholding","planned":true,"acquired":false,"shares":4349,"price":75.25,"value":327262.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 8,377 shares of Common Stock underlying the Reporting Person's RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 510 shares of the Issuer's Common Stock acquired by the Reporting Person on February 13, 2026 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3."}],"balance_after":124455,"source":{"system":"sec-edgar","filing":"0001470831-26-000186","document":"wk-form4_1771457961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083126000186/wk-form4_1771457961.xml","form_type":"4"}},{"id":967958,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-12-16T23:24:17.000Z","date":"2025-12-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":2003,"price":75.15,"value":150525.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 3,944 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":128294,"source":{"system":"sec-edgar","filing":"0001470831-25-000418","document":"wk-form4_1765927454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083125000418/wk-form4_1765927454.xml","form_type":"4"}},{"id":974745,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-12-10T12:53:52.000Z","date":"2025-12-08","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":74.26,"value":148520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025."}],"balance_after":130297,"source":{"system":"sec-edgar","filing":"0001470831-25-000392","document":"wk-form4_1765371229.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083125000392/wk-form4_1765371229.xml","form_type":"4"}},{"id":996219,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-11-19T00:23:28.000Z","date":"2025-11-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":4781,"price":66.39,"value":317410.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,410 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":132297,"source":{"system":"sec-edgar","filing":"0001470831-25-000349","document":"wk-form4_1763511805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000147083125000349/wk-form4_1763511805.xml","form_type":"4"}},{"id":1062266,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-08-19T23:40:45.000Z","date":"2025-08-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":4781,"price":51.32,"value":245360.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,409 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":137078,"source":{"system":"sec-edgar","filing":"0000950170-25-110276","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000095017025110276/ownership.xml","form_type":"4"}},{"id":1070535,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-08-11T22:29:56.000Z","date":"2025-08-07","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":45.44,"value":45440.0,"ownership":{"direct":true},"balance_after":141859,"source":{"system":"sec-edgar","filing":"0000950170-25-106751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000095017025106751/ownership.xml","form_type":"4"}},{"id":1140768,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-20T21:05:15.000Z","date":"2025-05-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":4780,"price":33.84,"value":161755.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 9,408 shares of Common Stock underlying the Reporting Person's Restricted Stock Units."}],"balance_after":142859,"source":{"system":"sec-edgar","filing":"0000950170-25-075340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000095017025075340/ownership.xml","form_type":"4"}},{"id":1157629,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-05-06T20:45:19.000Z","date":"2025-05-02","kind":"sale","planned":false,"acquired":false,"shares":1026,"price":38.5079,"value":39509.1054,"ownership":{"direct":true},"balance_after":147639,"source":{"system":"sec-edgar","filing":"0000950170-25-064567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000095017025064567/ownership.xml","form_type":"4"}},{"id":1194886,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":22387,"kind":"person","name":"Apuli Maricel","position":1,"cik":"0002058197","reported_name":"Apuli Maricel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2025-03-21T22:03:23.000Z","date":"2025-03-19","kind":"grant","planned":false,"acquired":true,"shares":23660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/16th of the underlying shares on May 16, 2025, and as to 1/16th of the underlying shares each quarter thereafter until fully vested, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":148665,"source":{"system":"sec-edgar","filing":"0000950170-25-043376","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058197/000095017025043376/ownership.xml","form_type":"4"}}]}